{"id":1516,"date":"2024-04-19T19:52:24","date_gmt":"2024-04-19T17:52:24","guid":{"rendered":"https:\/\/www.nuvr.cz\/?p=1516"},"modified":"2024-04-19T19:52:24","modified_gmt":"2024-04-19T17:52:24","slug":"a-new-strategy-to-determine-whether-nanomedicines-will-be-effective-for-a-patient","status":"publish","type":"post","link":"https:\/\/www.nuvr.cz\/en\/2024\/04\/19\/a-new-strategy-to-determine-whether-nanomedicines-will-be-effective-for-a-patient\/","title":{"rendered":"A new strategy to determine whether nanomedicines will be effective for a patient"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Scientists from the Institute of Macromolecular Chemistry of the CAS, led by Tom\u00e1\u0161 Etrych, whose research group is part of the NIRC, have been involved in developing a strategy to determine whether treatment with advanced forms of nanomedicines will be of significant benefit to patients or remain without effect. Recent research results have been published in <\/span><a href=\"https:\/\/www.nature.com\/articles\/s41551-024-01197-4\"><span style=\"font-weight: 400;\">Nature Biomedical Engineering<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to<\/span><a href=\"https:\/\/www.avcr.cz\/cs\/pro-media\/tiskove-zpravy\/Vedci-vyvinuli-strategii-jak-urcit-zda-bude-nanoterapie-ucinna-pro-pacienta\/\"><span style=\"font-weight: 400;\"> a press release from the CAS<\/span><\/a><span style=\"font-weight: 400;\">, a total of 12 teams from 4 European countries (Czech Republic, Netherlands, Germany, UK) and Singapore participated in the comprehensive research. The researchers identified 23 tumor markers and compared them to how nanomedicines accumulate in selected tumor models using machine learning. For the study, the experts chose two representatives of the most commonly studied types of nanosystems for cancer treatment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&#8220;Our task was to prepare one of the two model nanosystems used in the study. It had to meet several conditions: it had to be free of adverse side effects and at the same time exhibit a unique ability to accumulate in the tissue of the model tumours studied,&#8221; says Tom\u00e1\u0161 Etrych, adding that fluorescence molecular tomography was then used to study tumour accumulation and the fate of the nanosystem in detail in laboratory animals. The results of the research can significantly increase the likelihood of clinical success of nanomedicines under development.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-1519 alignleft\" src=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-1024x303.png\" alt=\"\" width=\"1024\" height=\"303\" srcset=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-1024x303.png 1024w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-300x89.png 300w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-768x227.png 768w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-150x44.png 150w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/Sni\u0301mek-obrazovky-2024-04-19-v-19.50.20-1-480x142.png 480w\" sizes=\"auto, (max-width:767px) 480px, (max-width:1024px) 100vw, 1024px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Schematic description of the developed strategy from tumor accumulation to evaluation by correlation analysis<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">Fig.: Institute of Macromolecular Chemistry of the CAS<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientists from the Institute of Macromolecular Chemistry of the CAS, led by Tom\u00e1\u0161 Etrych, whose research group is part of the NIRC, have been involved in developing a strategy to determine whether treatment with advanced forms of nanomedicines will be of significant benefit to patients or remain without effect.<\/p>\n","protected":false},"author":3,"featured_media":1196,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[80],"tags":[],"class_list":["post-1516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuality-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/comments?post=1516"}],"version-history":[{"count":1,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1516\/revisions"}],"predecessor-version":[{"id":1521,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1516\/revisions\/1521"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/media\/1196"}],"wp:attachment":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/media?parent=1516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/categories?post=1516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/tags?post=1516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}